Evaluation of hemostasis parameters before and after delivery in pregnancies with SIH and preeclampsia compared with normal pregnancies;Pra- und postpartale hamostaseologische Besonderheiten bei schwangerschaftsinduzierter Hypertonie (SIH) und Praeklampsie verglichen mit normotensiven Schwangerschaften

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 200, Issue 3, 1996, Pages 104-108

  Hofmann, M ^a   Casper, F ^a   Prellwitz, W ^b   Brockerhoff, P ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Inst F Klin Chem L   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; DIMER; THROMBIN; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE HYDROLASE;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; THROMBOCYTE FUNCTION; BLOOD; BLOOD CLOTTING TEST; HYPERTENSION; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PUERPERAL DISORDER; REFERENCE VALUE; THROMBOCYTE AGGREGATION;

ADULT; ANTITHROMBIN III; BLOOD COAGULATION TESTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; HYPERTENSION; INFANT, NEWBORN; PEPTIDE HYDROLASES; PLATELET AGGREGATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PUERPERAL DISORDERS; REFERENCE VALUES;

EID: 0030139236     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ballegeer, V. C., B. Spitz, L. A. de Baene, A. F. van Asche, M. Hidajat, A. M. Criel: Platelet activation and vascular damage in gestational hypertension. Am. J. Obstet. Gynecol. 166/2 (1992) 629
2. Benedetto, C., M. Massobrio, E. Bertini, M. Abbondanza, N. Enrieu, C. Tetta: Reduced serum inhibition of platelet-activating factor activity in preeclampsia. Am. J. Obstet. Gynecol. 160/1 (1989) 100
3. Boer, K. de, J. W. ten Cate, A. Sturk, J. J. J. Borm, P. E. Treffers: Enhanced thrombin generation in normal and hypertensive pregnancy. Am. J. Obstet. Gynecol. 160/1 (1989) 95
4. Boer, K. de, I. Lecander, J. W. ten Cate, J. J. J. Borm, P. E. Treffers: Placental-type plasminogen activator inhibitor in preeclampsia: Am. J. Obstet. Gynecol. 158/3 (1988) 518
5. Cadroy, Y., B. Boneu: Gerinnung bei normaler Schwangerschaft und bei Gestose. Diagnose & Labor 44 (1994) 86
6. Franke, M., R. Hafter, R. von Hugo, M. Röbl, H. Graeff: Ein Test zum Nachweis von Fibrin im Plasma. Geburtsh. u. Frauenheilk. 46 (1986) 105
7. Gaffney, P. J., L. J. Creighton, R. Harris, M. J. Perry: Monoclonal antibodies (mabs) to crosslinked fibrin fragments: their characterisation and potential clinical use. In: Müller-Berghaus, G., Scheefers-Borchel, U., Selmayr, E., Henschen, A. (eds.) Fibrinogen and its derivatives. Elsevier (1986) 273
8. Heilmann, L.: Hämorheologie und Schwangerschaftshochdruck. Zentralbl. Gynakol. 116 (1994) 195
9. Heilmann, L., B. Hojnacki, E. Spannuth: Hämostase und Präeklampsie. Geburtsh. u. Frauenheilkd. 51 (1991) 223
10. Ho, C. H., Z. L. Yang: The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb. Haemostasis 67/2 (1992) 214
11. Hoek, J. A., A. Sturk, J. W. ten Cate, R. J. Lamping, F. Berends, J. J. J. Borm: Laboratory and Clinical Evaluation of an Assay of Thrombin-Antithrombin III Complex in Plasma. Clin. Chem. 34/10 (1988) 2058
12. Horn, E. H.: Platelets in normal and hypertensive pregnancy. Platelets 2/4 (1991) 183
13. Lippert, T. H.: Über die Bedeutung der Prostaglandine und anderer Eicosanoide für die Physiologie und Pathophysiologie der Schwangerschaft. Geburtsh. u. Frauenheilkd. 46/2 (1986) 71
14. Mammen, E. F.: Oral contraceptives and blood coagulation: A critical review. Am. J. Obstet. Gynec. 142 (1982) 781
15. McKay, D. G.: Chronic intravascular coagulation in normal pregnancy and preeclampsia. Contrib. Nephrol. 25 (1982) 108
16. Mosesson, M. W.: D-Dimer, an ambiguous marker of thrombolysis. J. Lab. Med. 6 (1989) 662
17. Ness, P. M., S. A. Budzynski, A. Olexa, R. Rodvien: Congenital hypofibrinogenemia and recurrent placental abruption. Obstet. and Gynec. 61 (1983) 519
18. Nieuwenhuizen, W.: The use of monoclonal antibodies in demonstrating different fibrinogen derivatives. In: Müller-Berghaus, G., Scheefers-Borchel, U., Selmayr, F., Henschen, A. (eds) Fibrinogen and ist derivatives. Elsevier (1986) 245
19. Pritchard, J. A.: Chronic hypofibrinogenemia and frequent placental abortion. Obstet. and Gynec. 18 (1961) 146
20. Rath, W., W. Loos, W. Kuhn: Das HELLP-Syndrom. Zentralbl. Gynakol. 116 (1994) 195
21. Rath, W., J. Schrader: Endothelin-mögliche Bedeutung für Schwangerschaft und Schwangerschaftshypertonie. Zentralbl. Gynakol. 115/9 (1993) 388
22. Redman, C. W. G., J. Bonnar, I., Beilin: Early platelet consumption in pre-eclampsia. Br. Med. J. 1 (1978) 467
23. Reinthaller, A., G. Mursch-Edlmayr, G. Tatra: Thrombin-anti-thrombin III complex levels in normal pregnancy with hypertensive discorders and after delivery, 97 (1990) 506
24. Retzke, U., H. Graf: Die neue Terminologie und Klassifikation hypertensiver Erkrankungen in der Schwangerschaft. Zentralbl. Gynakol. 116 (1994) 61
25. Roberts, J. M., R. N. Taylor, A. Goldfien: Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens. 4/8 (1991) 700
26. Saleh, A. A., S. F. Bottoms, A. M. Farag, M. P. Dombrowski, R. A. Welch, G. Norman, E. F. Mammen: Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch. Gynecol. Obstet. 251/3 (1992) 105
27. Seitz, R., R. Egbring, C. Wagner, F. Dati: Thrombin-Antithrombin-III-Komplex (TAT): Ein Marker für intravasale Gerinnungsaktivierung. Internist 31 (1990) 69
28. Sen, C., R. Madazh, C. Kavuzlu, V. Ocak, N. Tolun: The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy. J. Perinat. Med. 22/1 (1994) 29
29. Terao, T., M. Maki, T. Ikenoue, K. Gotoh, M. Murata, H. Iwasaki, I. Shibata, M. Nakabayahi, M. Muraoka, Y. Takeda, S. Sakamoto, T. Kobayashi, N. Imai, H. Oda, H. Sameshima: The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. Gynecol. Obstet. Invest. 31/2 (1991) 74
30. Weiner, C. P., J. Brandt: Plasma antithrombin III activity: An aid in the diagnosis of preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 142/ 3 (1982) 275
31. Wersch, J. W. J. van, J. M. H. Ubachs: Blood coagulation and fibrinolysis during normal pregnancy. Europ. J. clin. Cehm. Biochem. 29 (1991) 45
32. Wieding, J. U., G. Eisinger, H. Köstering: Diagnostik der disseminierten intravasalen Gerinnung: Aussagekraft von löslichem Fibrin, D-Dimeren und Fibrin(ogen)-Spaltprodukten. Klin. Wochenschr. 67 (1989) 764
33. Wilde, J. T., S. Kitchen, S. Kinsev, M. Greaves, F. E. Presten: Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. British Journal of Haematology 71 (1989) 65
34. Zahradnik, H. P., W. Schäfer, K. Wetzka, M. Breckwoldt: Hypertensive disorders in pregnancy. The role of eicosanoids. Eicosanoids 4/3 (1991) 123